Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	potassium ion transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	2.29e-09	167	43	8	GO:0015079
GeneOntologyMolecularFunction	potassium channel activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	1.00e-08	128	43	7	GO:0005267
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	8.01e-08	102	43	6	GO:0005249
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	8.51e-07	152	43	6	GO:0022843
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	2.43e-06	182	43	6	GO:0005244
GeneOntologyMolecularFunction	voltage-gated channel activity	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	2.59e-06	184	43	6	GO:0022832
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	5.77e-06	465	43	8	GO:0046873
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	6.08e-06	627	43	9	GO:0022890
GeneOntologyMolecularFunction	gated channel activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	6.61e-06	334	43	7	GO:0022836
GeneOntologyMolecularFunction	monoatomic cation channel activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	7.86e-06	343	43	7	GO:0005261
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	9.64e-06	664	43	9	GO:0008324
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	2.76e-05	758	43	9	GO:0015318
GeneOntologyMolecularFunction	inward rectifier potassium channel activity	KCNH6 KCNH7 KCNH2	2.93e-05	28	43	3	GO:0005242
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	KCNH6 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	3.93e-05	793	43	9	GO:0015075
GeneOntologyMolecularFunction	monoatomic ion channel activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	5.10e-05	459	43	7	GO:0005216
GeneOntologyMolecularFunction	channel activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	1.18e-04	525	43	7	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	KCNH6 KCNH7 TMEM87A KCNH2 KCNH4 KCNH3 KCNH5	1.20e-04	526	43	7	GO:0022803
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2C KMT2D	1.26e-04	8	43	2	GO:0140945
GeneOntologyMolecularFunction	transmembrane transporter activity	KCNH6 NAT1 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	1.60e-04	1180	43	10	GO:0022857
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2C KMT2D	2.02e-04	10	43	2	GO:0140999
GeneOntologyMolecularFunction	transporter activity	KCNH6 NAT1 KCNH7 ATP12A TMEM87A SLC15A4 KCNH2 KCNH4 KCNH3 KCNH5	3.27e-04	1289	43	10	GO:0005215
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2C KMT2D	8.40e-04	20	43	2	GO:0042800
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 HTT	2.88e-03	37	43	2	GO:0045505
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	KCNH6 KCNH7 KCNH2	3.39e-03	140	43	3	GO:0099094
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2C KMT2D	4.05e-03	44	43	2	GO:0140938
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	KMT2C KMT2D TARBP1	6.02e-03	172	43	3	GO:0008757
GeneOntologyBiologicalProcess	potassium ion transmembrane transport	KCNH6 KCNH7 ATP12A P2RY12 KCNH2 KCNH4 KCNH3 KCNH5	1.93e-08	232	42	8	GO:0071805
GeneOntologyBiologicalProcess	potassium ion transport	KCNH6 KCNH7 ATP12A P2RY12 KCNH2 KCNH4 KCNH3 KCNH5	6.61e-08	272	42	8	GO:0006813
GeneOntologyBiologicalProcess	inorganic cation transmembrane transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	1.61e-06	922	42	11	GO:0098662
GeneOntologyBiologicalProcess	monoatomic cation transmembrane transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	1.98e-06	942	42	11	GO:0098655
GeneOntologyBiologicalProcess	inorganic ion transmembrane transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	4.15e-06	1017	42	11	GO:0098660
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	9.97e-06	1115	42	11	GO:0034220
GeneOntologyBiologicalProcess	monoatomic cation transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	1.41e-05	1157	42	11	GO:0006812
GeneOntologyBiologicalProcess	metal ion transport	KCNH6 KCNH7 ATP12A P2RY12 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	2.44e-05	1000	42	10	GO:0030001
GeneOntologyBiologicalProcess	monoatomic ion transport	KCNH6 KCNH7 ATP12A P2RY12 SLC15A4 KCNH2 FFAR1 KCNH4 HTT KCNH3 KCNH5	6.90e-05	1374	42	11	GO:0006811
GeneOntologyBiologicalProcess	long-chain fatty acid catabolic process	CYP4F2 AIG1	2.64e-04	12	42	2	GO:0042758
GeneOntologyBiologicalProcess	toll-like receptor 7 signaling pathway	UNC93B1 SLC15A4	2.64e-04	12	42	2	GO:0034154
GeneOntologyBiologicalProcess	positive regulation of transport	NRDE2 EEF2K CYP4F2 SMPD3 FCN3 P2RY12 KCNH2 FFAR1 HTT	2.68e-04	1081	42	9	GO:0051050
GeneOntologyCellularComponent	transmembrane transporter complex	KCNH6 KCNH7 ATP12A KCNH2 KCNH4 KCNH3 KCNH5	8.70e-05	523	43	7	GO:1902495
GeneOntologyCellularComponent	monoatomic ion channel complex	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.16e-04	378	43	6	GO:0034702
GeneOntologyCellularComponent	transporter complex	KCNH6 KCNH7 ATP12A KCNH2 KCNH4 KCNH3 KCNH5	1.19e-04	550	43	7	GO:1990351
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C KMT2D	2.69e-04	12	43	2	GO:0044666
GeneOntologyCellularComponent	voltage-gated potassium channel complex	KCNH2 KCNH4 KCNH5	8.68e-04	91	43	3	GO:0008076
GeneOntologyCellularComponent	potassium channel complex	KCNH2 KCNH4 KCNH5	1.28e-03	104	43	3	GO:0034705
Domain	PAS_9	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.86e-14	10	42	6	PF13426
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	2.64e-13	14	42	6	IPR003938
Domain	PAS-assoc_C	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.16e-11	24	42	6	IPR000700
Domain	PAC	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.98e-11	26	42	6	SM00086
Domain	PAC	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.98e-11	26	42	6	PS50113
Domain	PAC	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.98e-11	26	42	6	IPR001610
Domain	CNMP_BINDING_1	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	7.73e-11	32	42	6	PS00888
Domain	CNMP_BINDING_2	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	7.73e-11	32	42	6	PS00889
Domain	cNMP	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.14e-10	34	42	6	SM00100
Domain	PAS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.14e-10	34	42	6	IPR000014
Domain	PAS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.14e-10	34	42	6	PS50112
Domain	cNMP_binding	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.14e-10	34	42	6	PF00027
Domain	cNMP-bd_dom	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.38e-10	35	42	6	IPR000595
Domain	CNMP_BINDING_3	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.38e-10	35	42	6	PS50042
Domain	cNMP-bd-like	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	2.33e-10	38	42	6	IPR018490
Domain	-	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.02e-09	48	42	6	2.60.120.10
Domain	RmlC-like_jellyroll	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.49e-09	51	42	6	IPR014710
Domain	PAS	KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	8.66e-09	32	42	5	SM00091
Domain	K_chnl_volt-dep_ERG	KCNH6 KCNH7 KCNH2	1.06e-08	3	42	3	IPR003967
Domain	Ion_trans_dom	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.99e-07	114	42	6	IPR005821
Domain	Ion_trans	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.99e-07	114	42	6	PF00520
Domain	K_chnl_volt-dep_ELK	KCNH4 KCNH3	1.48e-05	3	42	2	IPR003950
Domain	PAS_fold_3	KCNH7 KCNH4 KCNH3	1.81e-05	23	42	3	IPR013655
Domain	PAS_3	KCNH7 KCNH4 KCNH3	1.81e-05	23	42	3	PF08447
Domain	PAS	KCNH6 KCNH2 KCNH5	2.35e-05	25	42	3	PF00989
Domain	PAS_fold	KCNH6 KCNH2 KCNH5	2.35e-05	25	42	3	IPR013767
Domain	FYrich_C	KMT2C KMT2D	4.92e-05	5	42	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	4.92e-05	5	42	2	IPR003888
Domain	FYRC	KMT2C KMT2D	4.92e-05	5	42	2	SM00542
Domain	FYRN	KMT2C KMT2D	4.92e-05	5	42	2	SM00541
Domain	FYRN	KMT2C KMT2D	4.92e-05	5	42	2	PF05964
Domain	FYRC	KMT2C KMT2D	4.92e-05	5	42	2	PF05965
Domain	FYRC	KMT2C KMT2D	4.92e-05	5	42	2	PS51543
Domain	FYRN	KMT2C KMT2D	4.92e-05	5	42	2	PS51542
Domain	CENP-B_N	TIGD3 TIGD6	2.20e-04	10	42	2	PF04218
Domain	CENPB	TIGD3 TIGD6	3.21e-04	12	42	2	SM00674
Domain	HTH_Psq	TIGD3 TIGD6	3.21e-04	12	42	2	IPR007889
Domain	DDE_1	TIGD3 TIGD6	3.21e-04	12	42	2	PF03184
Domain	HTH_PSQ	TIGD3 TIGD6	3.21e-04	12	42	2	PS50960
Domain	DDE_SF_endonuclease_dom	TIGD3 TIGD6	3.21e-04	12	42	2	IPR004875
Domain	HTH_Tnp_Tc5	TIGD3 TIGD6	3.79e-04	13	42	2	PF03221
Domain	HTH_CenpB_DNA-bd_dom	TIGD3 TIGD6	3.79e-04	13	42	2	IPR006600
Domain	HTH_CENPB	TIGD3 TIGD6	3.79e-04	13	42	2	PS51253
Domain	Post-SET_dom	KMT2C KMT2D	5.81e-04	16	42	2	IPR003616
Domain	PostSET	KMT2C KMT2D	5.81e-04	16	42	2	SM00508
Domain	POST_SET	KMT2C KMT2D	5.81e-04	16	42	2	PS50868
Domain	EPHD	KMT2C KMT2D	1.11e-03	22	42	2	PS51805
Domain	SET	KMT2C KMT2D	3.83e-03	41	42	2	PF00856
Domain	SET	KMT2C KMT2D	4.80e-03	46	42	2	SM00317
Domain	SET_dom	KMT2C KMT2D	5.65e-03	50	42	2	IPR001214
Domain	SET	KMT2C KMT2D	5.65e-03	50	42	2	PS50280
Domain	HMG_box	KMT2C KMT2D	6.33e-03	53	42	2	PF00505
Domain	HMG	KMT2C KMT2D	6.56e-03	54	42	2	SM00398
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.48e-10	41	28	6	MM14546
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	2.01e-10	43	28	6	M1056
Pathway	REACTOME_POTASSIUM_CHANNELS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	3.22e-08	98	28	6	MM14545
Pathway	REACTOME_POTASSIUM_CHANNELS	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	4.34e-08	103	28	6	M1073
Pathway	REACTOME_NEURONAL_SYSTEM	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	4.17e-05	335	28	6	MM14503
Pathway	REACTOME_NEURONAL_SYSTEM	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	1.29e-04	411	28	6	M735
Pubmed	Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate.	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	5.19e-16	10	43	6	26503718
Pubmed	International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	9.23e-12	40	43	6	16382104
Pubmed	Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome.	KCNH6 KCNH7 KCNH2	1.76e-09	3	43	3	35818223
Pubmed	Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3.	KCNH6 KCNH7 KCNH2	1.76e-09	3	43	3	14643686
Pubmed	HERG K(+) currents in human prolactin-secreting adenoma cells.	KCNH6 KCNH7 KCNH2	1.76e-09	3	43	3	12634931
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	1.49e-06	2	43	2	28483418
Pubmed	New ether-à-go-go K(+) channel family members localized in human telencephalon.	KCNH4 KCNH3	1.49e-06	2	43	2	10455180
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	1.49e-06	2	43	2	36869380
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	1.49e-06	2	43	2	28967912
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	1.49e-06	2	43	2	34156443
Pubmed	Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons.	KCNH7 KCNH2	1.49e-06	2	43	2	19359372
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	1.49e-06	2	43	2	25346535
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	1.49e-06	2	43	2	31924266
Pubmed	Functional analysis of a mouse brain Elk-type K+ channel.	KCNH2 KCNH3	1.49e-06	2	43	2	10191308
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	1.49e-06	2	43	2	27280393
Pubmed	The eag family of K+ channels in Drosophila and mammals.	KCNH6 KCNH7	1.49e-06	2	43	2	10414305
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	1.49e-06	2	43	2	36601880
Pubmed	Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma.	KMT2C KMT2D	4.48e-06	3	43	2	22183980
Pubmed	Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization.	KCNH7 KCNH2	4.48e-06	3	43	2	15961404
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2D	4.48e-06	3	43	2	23932714
Pubmed	HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.	KMT2C KMT2D	4.48e-06	3	43	2	21683083
Pubmed	Distribution and functional properties of human KCNH8 (Elk1) potassium channels.	KCNH4 KCNH3	4.48e-06	3	43	2	12890647
Pubmed	Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis.	KCNH6 KCNH7 KCNH2	4.49e-06	26	43	3	31138815
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2C KMT2D	8.94e-06	4	43	2	19221051
Pubmed	Cancer gene mutation frequencies for the U.S. population.	KMT2C KMT2D	8.94e-06	4	43	2	34645806
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	KMT2C KMT2D	8.94e-06	4	43	2	28398509
Pubmed	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	KMT2C KMT2D	8.94e-06	4	43	2	24081332
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2C KMT2D	8.94e-06	4	43	2	23129768
Pubmed	MLL3/MLL4-Associated PAGR1 Regulates Adipogenesis by Controlling Induction of C/EBPβ and C/EBPδ.	KMT2C KMT2D	1.49e-05	5	43	2	32601106
Pubmed	Differences in neuroinvasion and protective innate immune pathways between encephalitic California Serogroup orthobunyaviruses.	IRF3 UNC93B1	1.49e-05	5	43	2	35245345
Pubmed	Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF.	KMT2C KMT2D	1.49e-05	5	43	2	31127101
Pubmed	Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus.	IRF3 UNC93B1	1.49e-05	5	43	2	20592086
Pubmed	A PTIP-PA1 subcomplex promotes transcription for IgH class switching independently from the associated MLL3/MLL4 methyltransferase complex.	KMT2C KMT2D	1.49e-05	5	43	2	26744420
Pubmed	Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.	UNC93B1 SLC15A4	2.23e-05	6	43	2	29055005
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	KMT2C KMT2D	2.23e-05	6	43	2	17021013
Pubmed	Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.	KCNH6 KCNH7 KCNH2 KCNH3	2.67e-05	139	43	4	16985003
Pubmed	Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.	IRF3 UNC93B1	3.12e-05	7	43	2	25008929
Pubmed	Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4.	KMT2C KMT2D	3.12e-05	7	43	2	30604749
Pubmed	Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers.	KMT2C KMT2D	3.12e-05	7	43	2	36598580
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	KMT2C KMT2D	3.12e-05	7	43	2	19556342
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	KMT2C KMT2D RAB3GAP2	3.31e-05	50	43	3	37974198
Pubmed	H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development.	KMT2C KMT2D	4.16e-05	8	43	2	30335158
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2C KMT2D	4.16e-05	8	43	2	23130995
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	KMT2C KMT2D	4.16e-05	8	43	2	22266653
Pubmed	Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.	KMT2C KMT2D	4.16e-05	8	43	2	21447625
Pubmed	In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.	IRF3 UNC93B1	5.35e-05	9	43	2	26880763
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	KMT2C KMT2D	5.35e-05	9	43	2	22665483
Pubmed	Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.	KCNH2 KCNH5	6.68e-05	10	43	2	22855790
Pubmed	MLL3/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner.	KMT2C KMT2D	8.15e-05	11	43	2	37012455
Pubmed	Toll-like receptor 7 mediates early innate immune responses to malaria.	IRF3 UNC93B1	9.78e-05	12	43	2	24042114
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	KMT2C KMT2D	9.78e-05	12	43	2	27563068
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	KMT2C KMT2D	1.15e-04	13	43	2	17761849
Pubmed	Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening.	UNC93B1 SLC15A4	1.15e-04	13	43	2	12935356
Pubmed	Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.	KMT2C KMT2D	1.15e-04	13	43	2	21502505
Pubmed	Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental candidiasis.	IRF3 UNC93B1	1.35e-04	14	43	2	22777843
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	KMT2C KMT2D	1.35e-04	14	43	2	12482968
Pubmed	Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.	UNC93B1 SLC15A4	1.55e-04	15	43	2	21045126
Pubmed	The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.	KMT2C KMT2D	1.55e-04	15	43	2	17925232
Pubmed	Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.	P2RY12 HTT	1.77e-04	16	43	2	27721240
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	KMT2C KMT2D	1.77e-04	16	43	2	24368734
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	CHD2 TMEM87A TARBP1 RAB3GAP2 TIGD6 KCNH5	1.89e-04	686	43	6	29987050
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	KMT2C KMT2D	2.01e-04	17	43	2	26180087
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	KMT2C KMT2D	2.26e-04	18	43	2	17500065
Pubmed	TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects.	IRF3 UNC93B1	2.52e-04	19	43	2	28400473
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2C KMT2D	2.80e-04	20	43	2	29785026
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	KMT2C KMT2D	2.80e-04	20	43	2	19047629
Pubmed	The histone H3-lysine 4-methyltransferase Mll4 regulates the development of growth hormone-releasing hormone-producing neurons in the mouse hypothalamus.	KMT2C KMT2D	2.80e-04	20	43	2	33431871
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KMT2C KMT2D	3.09e-04	21	43	2	27626377
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2C KMT2D	3.40e-04	22	43	2	26886794
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FBRSL1 TIGD3 KMT2C KMT2D KCNH2 HTT KCNH3	3.80e-04	1105	43	7	35748872
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	KMT2C KMT2D TARBP1	4.36e-04	119	43	3	23508102
Pubmed	Identification and characterization of a novel human PP1 phosphatase complex.	KMT2C KMT2D	6.79e-04	31	43	2	20516061
Pubmed	MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation.	KMT2C KMT2D	7.69e-04	33	43	2	32439762
Interaction	KCNH4 interactions	KCNH6 KCNH2 KCNH4 KCNH3 KCNH5	2.41e-11	12	42	5	int:KCNH4
Interaction	KCNH6 interactions	KCNH6 KCNH4	4.24e-06	2	42	2	int:KCNH6
Interaction	KCNH3 interactions	KCNH4 KCNH3	4.22e-05	5	42	2	int:KCNH3
Cytoband	7q36.1	KMT2C KCNH2	2.22e-03	74	43	2	7q36.1
GeneFamily	Potassium voltage-gated channels	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	7.78e-12	40	23	6	274
GeneFamily	Helix-turn-helix CENPB type domain containing	TIGD3 TIGD6	1.20e-04	13	23	2	533
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2C KMT2D	8.47e-04	34	23	2	487
GeneFamily	PHD finger proteins	KMT2C KMT2D	5.79e-03	90	23	2	88
GeneFamily	Endogenous ligands	BMP5 HTT	3.61e-02	237	23	2	542
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH6 CYP4F2 KCNH7 KCNH2 KCNH5	1.25e-06	196	43	5	95544097577f20ed7f4144bd940471cde0617554
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	SMPD3 KCNH4 KCNH3 KCNH5	1.19e-05	146	43	4	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	Globus_pallidus-Neuronal-Excitatory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SMPD3 KCNH4 KCNH3 KCNH5	1.71e-05	160	43	4	f843287ed57d2d5a3b3f6dfb03b6934e330e6645
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SMPD3 KCNH4 KCNH3 KCNH5	1.75e-05	161	43	4	ebcd5066e82b7760b9da6adc02d11258d1309dab
ToppCell	ILEUM-inflamed-(3)_pDC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TIGD3 UNC93B1 SMPD3 SLC15A4	2.48e-05	176	43	4	b9f847dd55703e413f3cd815eef5724fffaf13b3
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	KCNH6 KCNH7 SMPD3 KCNH2	2.83e-05	182	43	4	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KCNH6 KCNH7 SMPD3 KCNH2	3.08e-05	186	43	4	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KCNH6 KCNH7 SMPD3 KCNH2	3.21e-05	188	43	4	c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH6 KCNH7 KCNH2 KCNH5	3.34e-05	190	43	4	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH6 KCNH7 KCNH2 KCNH5	3.34e-05	190	43	4	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH6 KCNH7 KCNH2 KCNH5	3.34e-05	190	43	4	a9a705455019e28d655636de73b07540798f82e6
ToppCell	11.5-Airway-Epithelial-Neuroendocrine\|Airway / Age, Tissue, Lineage and Cell class	TIGD3 KCNH6 SMPD3 KCNH2	3.41e-05	191	43	4	c1bb3ae5c297f55cdadf5b6e53d5296389d5099e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH6 KCNH7 SMPD3 KCNH2	3.93e-05	198	43	4	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH6 KCNH7 SMPD3 KCNH2	3.93e-05	198	43	4	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	MS-IIF-Myeloid-pDC\|IIF / Disease, condition lineage and cell class	TIGD3 UNC93B1 SMPD3 SLC15A4	4.00e-05	199	43	4	e262ee854e64d87460bee810c14d6cbe744460e8
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM150B DNHD1 HTT	3.25e-04	139	43	3	bb2b020dda32ddc60ec9952de5b01acee60b5b59
ToppCell	droplet-Lung-nan-3m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM150B NAT1 UNC93B1	3.76e-04	146	43	3	ed932d43e9efd064ee4b49ddef529f3d041be765
ToppCell	droplet-Lung-nan-3m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM150B NAT1 UNC93B1	3.76e-04	146	43	3	0d74962779055c774312d59fc3b1365163741c3a
ToppCell	Control-Epithelial-PNEC\|World / Disease state, Lineage and Cell class	KCNH6 KCNH7 KCNH2	3.99e-04	149	43	3	02b47193621d23a50378d7905d7f85aaab686cfb
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC93B1 SMPD3 P2RY12	4.47e-04	155	43	3	93bfcf5c12cbb61a1e0444312afd2aa411a8bf50
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM254 SMPD3 LXN	4.73e-04	158	43	3	4d997efc36fd8946775fe74dd9ac9ccd5ade64ff
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	TIGD3 SMPD3 SLC15A4	4.73e-04	158	43	3	2af7beb48272e5368d9ba6b80f08d47ab8556c08
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|367C / Donor, Lineage, Cell class and subclass (all cells)	TMEM254 IRF3 SLC15A4	5.00e-04	161	43	3	f470b662566131dfe69a2fd01186ac8491196396
ToppCell	LAM-Lymphoid-pDC\|LAM / Condition, Lineage and Cell class	TIGD3 SMPD3 SLC15A4	5.00e-04	161	43	3	bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a
ToppCell	390C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNHD1 SMPD3 FCN3	5.09e-04	162	43	3	fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCell	390C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNHD1 SMPD3 FCN3	5.09e-04	162	43	3	45be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell	ILEUM-non-inflamed-(3)_pDC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TIGD3 SMPD3 SLC15A4	5.18e-04	163	43	3	bc5411702badab39143905aa51676b4bbfad2041
ToppCell	mild-Myeloid-Eosinophils\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	EEF2K SMPD3 KCNH2	5.18e-04	163	43	3	7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa
ToppCell	Frontal_cortex\|World / BrainAtlas - Mouse McCarroll V32	KCNH7 ATP12A KCNH3	5.27e-04	164	43	3	e09291711abf8680e78170328313719092b0142f
ToppCell	metastatic_Brain-Myeloid_cells-pDCs\|metastatic_Brain / Location, Cell class and cell subclass	TIGD3 SMPD3 SLC15A4	5.27e-04	164	43	3	06db4cc064f0765c481ce880207823872c27bfa9
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SMPD3 LXN KCNH5	5.27e-04	164	43	3	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TIGD3 FBN2 KCNH2	5.37e-04	165	43	3	3d2acdae0dd2b79a15f74158e8e566ce22b4218e
ToppCell	droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM150B UNC93B1 PGGHG	5.46e-04	166	43	3	c215c4aede38d355d35fd26cd7ef2c19efecd0e6
ToppCell	facs-Tongue-nan-3m-Epithelial-basal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS11F P2RY12 SLC15A4	5.66e-04	168	43	3	ca0c4a819f9047fc40d224f7656fec60f6fa05d8
ToppCell	390C-Myeloid-Dendritic-pDC\|390C / Donor, Lineage, Cell class and subclass (all cells)	TIGD3 UNC93B1 SMPD3	5.66e-04	168	43	3	5a2e7a52b7330dce30823695a7b9b26bc47a69ce
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCNH6 CYP4F2 FFAR1	5.66e-04	168	43	3	0f736d58cb0ff042fa3ce58e36bde37b6976f8fc
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	UNC93B1 SMPD3 SLC15A4	5.75e-04	169	43	3	71f6761b9927f352e0ccc221ca373319915f4184
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM150B UNC93B1 PGGHG	5.75e-04	169	43	3	735655e75511c5c41aca667909e8bb52a0ad7fc6
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5\|TCGA-Bladder / Sample_Type by Project: Shred V9	TIGD3 KCNH6 KCNH3	5.75e-04	169	43	3	9c4e83fe8225d16173a103bf5a57b17d623be923
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KCNH6 KCNH7 KCNH2	5.75e-04	169	43	3	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	severe-Myeloid-Eosinophils\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	EEF2K SMPD3 KCNH2	5.85e-04	170	43	3	863f0266d5837cdbc3e09a3fe6a99dd3e6261674
ToppCell	droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM202 TMEM150B P2RY12	5.95e-04	171	43	3	7ca404539344e14dcd90c746c9122f713a7db78b
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TIGD3 SMPD3 SLC15A4	5.95e-04	171	43	3	4fd2c7977c512c51507f055fc74b111c0228ed8b
ToppCell	droplet-Lung-nan-18m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM202 TMEM150B P2RY12	5.95e-04	171	43	3	ab113c8e773b0af47a87aed50e96be3ba71c3c82
ToppCell	COVID_vent-Lymphocytic-Dendritic-pDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SMPD3 SLC15A4 TARBP1	5.95e-04	171	43	3	779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCell	COVID_vent-Lymphocytic-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SMPD3 SLC15A4 TARBP1	5.95e-04	171	43	3	debbb071d260639b16269c94d172766908325c58
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KCNH6 KCNH7 KCNH2	5.95e-04	171	43	3	f4321133190a3df9d31f5d4021a464d3840145f1
ToppCell	mild-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	EEF2K SMPD3 KCNH2	5.95e-04	171	43	3	5c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KCNH6 KCNH7 KCNH2	5.95e-04	171	43	3	ed4fb6c84579d99df33de5f8f928c3cd2f3d3d72
ToppCell	390C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TIGD3 SMPD3 SLC15A4	6.06e-04	172	43	3	3f894c74916d49a995b2d4651ca1c6733c14ce9c
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	KCNH7 SMPD3 KCNH3	6.06e-04	172	43	3	200b2e63313b110b8ca59ee5b72c02cc8ed907cd
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC93B1 SMPD3 SLC15A4	6.06e-04	172	43	3	b84610f1e5889a655652800c2b3270d264bfe1a9
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KCNH6 KCNH7 KCNH2	6.06e-04	172	43	3	d0cdedd734406988a9a93d7300c7b1a8b4b45c38
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBRSL1 SMPD3 TMEM87A	6.16e-04	173	43	3	4968712af1cca8c932abd3323631d7dcaffd4a66
ToppCell	wk_15-18-Hematologic-Myeloid-pDC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	UNC93B1 SMPD3 SLC15A4	6.16e-04	173	43	3	b571970e3ba88afc07041c5692ccfd85fc39e796
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EEF2K LXN KCNH4	6.26e-04	174	43	3	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4\|TCGA-Adrenal / Sample_Type by Project: Shred V9	TMEM254 CHD2 FBN2	6.26e-04	174	43	3	15e2b9f46404ff9575e149024b24cb17b50b02b5
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EEF2K LXN KCNH4	6.26e-04	174	43	3	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	IIF-Myeloid-pDC\|IIF / Disease, Lineage and Cell Type	UNC93B1 SMPD3 SLC15A4	6.37e-04	175	43	3	35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	KCNH7 KCNH2 FFAR1	6.37e-04	175	43	3	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	KCNH7 KCNH2 FFAR1	6.37e-04	175	43	3	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCNH6 KCNH7 FFAR1	6.37e-04	175	43	3	c031da47ca63d1133e13530cbf779df9435e22cb
ToppCell	CF-Lymphoid-pDC\|CF / Disease state, Lineage and Cell class	EEF2K SMPD3 TARBP1	6.47e-04	176	43	3	dd1e529a9e413bcaab43584afbe059e1464ffb53
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TIGD3 SMPD3 SLC15A4	6.58e-04	177	43	3	507f06d31ab773099c9431b6f433899dc97b5566
ToppCell	wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KY KCNH4 KCNH5	6.58e-04	177	43	3	15a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMP5 FBN2 KCNH2	6.58e-04	177	43	3	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TIGD3 SMPD3 SLC15A4	6.58e-04	177	43	3	8887ff6341eb070bdaa890cc2cd7745f0cf1b0af
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KY BMP5 KCNH3	6.58e-04	177	43	3	dbdbdc8ed9ef0b529694242ef9f9f07a42e16005
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KY BMP5 KCNH3	6.69e-04	178	43	3	416f85e51f45ec7949451fd47611a84e33e87245
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMPD3 SLC15A4 TARBP1	6.80e-04	179	43	3	c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	KCNH6 ATP12A KCNH2	6.80e-04	179	43	3	06f92c884189197c86793191c05f65e34925c097
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC93B1 SMPD3 SLC15A4	6.80e-04	179	43	3	bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	UNC93B1 SMPD3 SLC15A4	6.91e-04	180	43	3	6a2366d76276452141db1bd93013a9503525f574
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	EEF2K SMPD3 KCNH2	6.91e-04	180	43	3	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|tumor_Lung / Location, Cell class and cell subclass	UNC93B1 SMPD3 SLC15A4	7.02e-04	181	43	3	c864ffeb9234b8c29754afc91c85a972889617f4
ToppCell	wk_20-22-Hematologic-Myeloid-pDC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	UNC93B1 SMPD3 SLC15A4	7.02e-04	181	43	3	60607c5ff6d5b1cb416adc034491dca31c41e988
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH6 NAT1 KCNH2	7.13e-04	182	43	3	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UNC93B1 SMPD3 SLC15A4	7.13e-04	182	43	3	9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KMT2D KCNH7 SMPD3	7.13e-04	182	43	3	1923932a9c60e9ec33db69ded441210d1fb07bec
ToppCell	5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCNH6 KCNH7 FFAR1	7.13e-04	182	43	3	27a27a3eaeacb087c9601d5bb1c9e57cdfcd9d77
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UNC93B1 SMPD3 SLC15A4	7.13e-04	182	43	3	4602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KMT2D KCNH7 SMPD3	7.13e-04	182	43	3	69ff652f74cc47fbe0bd665ab17c445c5b959dad
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UNC93B1 SMPD3 SLC15A4	7.25e-04	183	43	3	df6fd0927b6e4cf9a1583969a68096e4bccfbace
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMP5 FBN2 KCNH2	7.25e-04	183	43	3	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UNC93B1 SMPD3 SLC15A4	7.25e-04	183	43	3	3b123571e10c132227aff65648b4b3c6acb4bd00
ToppCell	myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell\|World / Lineage, cell class and subclass	UNC93B1 SMPD3 SLC15A4	7.36e-04	184	43	3	11619778bc773ecd1a9867330be04deaf324f31e
ToppCell	control-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PHTF2 EEF2K KCNH2	7.36e-04	184	43	3	fad517d047e8eaeaa5bd4f311d770880568dd13c
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-pDC\|bone_marrow / Manually curated celltypes from each tissue	UNC93B1 SMPD3 SLC15A4	7.36e-04	184	43	3	2817d530863e85dfdcd143b7a3dc5fc58a9cd98b
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KY BMP5 FBN2	7.48e-04	185	43	3	8ed10ba581849c9c4ac4397226be2b62b4b3b900
ToppCell	Leuk-UTI-Other-RBC\|Leuk-UTI / Disease, Lineage and Cell Type	UNC93B1 SMPD3 SLC15A4	7.48e-04	185	43	3	5b5dd856d6efc0539d92533cff134bbc3f98be45
ToppCell	Leuk-UTI-Other\|Leuk-UTI / Disease, Lineage and Cell Type	UNC93B1 SMPD3 SLC15A4	7.48e-04	185	43	3	895e8087e97ac0eab3446385e6e0dd24bea7f42c
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KY BMP5 FBN2	7.48e-04	185	43	3	b8052cebb73f41abe6faf0aa847be7c8ef23ae94
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TIGD3 SMPD3 SLC15A4	7.48e-04	185	43	3	308a98f111895071d8772bc010554471cc12fab2
ToppCell	healthy_donor-Lymphocytic-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	916f2aeea4989ba7a29e071e348a51010f010223
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	b70cd94c651b56dcf2e55554533a5f1130845390
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	31df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH6 KCNH7 SMPD3	7.60e-04	186	43	3	c7983281a290201567b398e9ea6baddb96c692bb
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	a07694caf7fede06a47636725bcc7f09909cdf07
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCell	Multiple_Sclerosis-Myeloid-pDC\|Multiple_Sclerosis / Disease, Lineage and Cell Type	UNC93B1 SMPD3 SLC15A4	7.60e-04	186	43	3	330a4f669adea91ff9f2dff2de2210f5e3401e19
Drug	WAY-123,398	KCNH6 KCNH7 KCNH2 KCNH3 KCNH5	4.73e-12	10	43	5	CID000132160
Drug	Hdba	KCNH6 KCNH7 KCNH2 KCNH5	4.19e-08	19	43	4	CID000003896
Drug	MK-499	KCNH6 KCNH7 KCNH2 KCNH5	4.19e-08	19	43	4	CID000127718
Drug	pyraclofos	KCNH6 KCNH7 KCNH2 KCNH4 KCNH3 KCNH5	4.68e-08	106	43	6	CID000093460
Drug	E 4031	KCNH6 KCNH7 KCNH2 KCNH3 KCNH5	5.58e-08	54	43	5	CID000003184
Drug	ether-a	KCNH6 KCNH7 KCNH2 KCNH5	7.87e-08	22	43	4	CID000501025
Drug	terfenadine	KCNH6 KCNH7 KCNH2 KCNH3 KCNH5	1.04e-07	61	43	5	CID000005405
Drug	dofetilide	KCNH6 KCNH7 KCNH2 KCNH3 KCNH5	1.22e-07	63	43	5	CID000071329
Drug	Doxazosin	KCNH6 KCNH7 KCNH2	1.25e-07	6	43	3	DB00590
Drug	Prazosin	KCNH6 KCNH7 KCNH2	1.25e-07	6	43	3	DB00457
Drug	Terazosin	KCNH6 KCNH7 KCNH2	1.25e-07	6	43	3	DB01162
Drug	Miconazole	KCNH6 KCNH7 KCNH2	3.49e-07	8	43	3	DB01110
Drug	XE991	KCNH6 KCNH7 KCNH2 KCNH5	4.34e-07	33	43	4	CID000656732
Drug	Ibutilide	KCNH6 KCNH7 KCNH2	7.46e-07	10	43	3	DB00308
Drug	linopirdine	KCNH6 KCNH7 KCNH2 KCNH3	1.29e-06	43	43	4	CID000003932
Drug	astemizole	KCNH6 KCNH7 KCNH2 KCNH3	1.55e-06	45	43	4	CID000002247
Drug	sertindole	KCNH6 KCNH7 KCNH2 KCNH5	2.38e-06	50	43	4	CID000060149
Drug	ziprasidone	KCNH6 KCNH7 KCNH2 KCNH5	3.02e-06	53	43	4	CID000060853
Drug	N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine	KCNH6 KCNH2	3.48e-06	2	43	2	ctd:C531033
Drug	W-A-Y	KCNH6 KCNH7 KCNH2 KCNH3	3.77e-06	56	43	4	CID000004368
Drug	quetiapine	KCNH6 KCNH7 KCNH2 KCNH5	4.05e-06	57	43	4	CID000005002
Drug	clofilium	KCNH6 KCNH7 KCNH2 KCNH5	1.15e-05	74	43	4	CID000002798
Drug	thioridazine	KCNH6 KCNH7 KCNH2 KCNH5	1.49e-05	79	43	4	CID000005452
Drug	NS1643	KCNH6 KCNH2	2.09e-05	4	43	2	CID010177784
Drug	cisapride	KCNH6 KCNH7 KCNH2 KCNH5	5.91e-05	112	43	4	CID000002769
Drug	ether	KCNH6 KCNH7 KCNH2 KCNH5	6.11e-05	113	43	4	CID000003283
Drug	mM Q	KCNH6 KCNH7 KCNH2	6.36e-05	41	43	3	CID000445446
Drug	diazoxide	KCNH6 KCNH7 KCNH2 FFAR1 KCNH5	6.66e-05	227	43	5	CID000003019
Drug	AC1MRHRO	KCNH6 KCNH7 FFAR1	7.35e-05	43	43	3	CID003468412
Drug	pimozide	KCNH6 KCNH7 KCNH2 KCNH5	9.63e-05	127	43	4	CID000016362
Drug	Rubidium	ATP12A KCNH2	9.69e-05	8	43	2	ctd:D012413
Drug	olanzapine	KCNH6 KCNH7 KCNH2 KCNH5	1.02e-04	129	43	4	CID000004585
Drug	piperidine	KCNH6 KCNH7 KCNH2 KCNH3	1.05e-04	130	43	4	CID000008082
Drug	risperidone	KCNH6 KCNH7 KCNH2 KCNH5	1.25e-04	136	43	4	CID000005073
Drug	carbanilide	KCNH6 KCNH2	1.90e-04	11	43	2	CID000007595
Disease	long QT syndrome (implicated_via_orthology)	KCNH6 KCNH7 KCNH2	2.97e-07	10	41	3	DOID:2843 (implicated_via_orthology)
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	1.88e-06	2	41	2	DOID:0080598 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	KCNH6 KCNH7 ATP12A KCNH2 KCNH5	3.09e-06	163	41	5	DOID:1826 (implicated_via_orthology)
Disease	short QT syndrome (implicated_via_orthology)	KCNH6 KCNH2	5.65e-06	3	41	2	DOID:0050793 (implicated_via_orthology)
Disease	heart conduction disease (implicated_via_orthology)	KCNH6 KCNH7 KCNH2	1.20e-05	32	41	3	DOID:10273 (implicated_via_orthology)
Disease	Herpetic Acute Necrotizing Encephalitis	IRF3 UNC93B1	1.88e-05	5	41	2	C0001338
Disease	Herpetic meningoencephalitis	IRF3 UNC93B1	2.82e-05	6	41	2	C0019385
Disease	Herpes encephalitis	IRF3 UNC93B1	3.94e-05	7	41	2	C0276226
Disease	brain disease (is_implicated_in)	IRF3 UNC93B1	1.23e-04	12	41	2	DOID:936 (is_implicated_in)
Disease	Methionine sulfoxide measurement	KCNH6 SLC15A4	1.23e-04	12	41	2	EFO_0021650
Disease	Sezary Syndrome	KMT2C KMT2D	6.47e-04	27	41	2	C0036920
Disease	lung non-small cell carcinoma (is_implicated_in)	NAT1 KMT2C KMT2D	9.57e-04	139	41	3	DOID:3908 (is_implicated_in)
Disease	Bladder Neoplasm	NAT1 KMT2C KMT2D	9.77e-04	140	41	3	C0005695
Disease	Malignant neoplasm of urinary bladder	NAT1 KMT2C KMT2D	9.97e-04	141	41	3	C0005684
Disease	Congenital small ears	BMP5 KMT2D	1.49e-03	41	41	2	C0152423
Disease	oral microbiome measurement	KMT2C ATP12A	1.57e-03	42	41	2	EFO_0801229
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KMT2C KMT2D	1.80e-03	45	41	2	DOID:3748 (is_implicated_in)
Disease	Hernia	KY AIG1	2.30e-03	51	41	2	HP_0100790
Disease	Libman-Sacks Disease	P2RY12 SLC15A4	2.96e-03	58	41	2	C0242380
Disease	Benign Neoplasm	NAT1 KCNH2	4.05e-03	68	41	2	C0086692
Disease	Neoplasms	NAT1 KCNH2	4.05e-03	68	41	2	C0027651

Protein segments in the cluster

Peptide	Gene	Start	Entry
GWCLQVNHLLYWALT	NAT1	66	P18440
WCAVHVQIAWQIYRH	FBRSL1	591	Q9HCM7
SVGYILWVCWVHHVT	AIG1	166	Q9NVV5
WNYRDALAVIWSHEC	ADPRM	256	Q3LIE5
LAAWLWAVLHYGLAH	DNHD1	3326	Q96M86
AHWVACVWFYIGQRE	KCNH3	371	Q9ULD8
VLHAHCCWEYVVQWN	RAB3GAP2	1011	Q9H2M9
AVIVHGAWWYASCYR	FCN3	246	O75636
LWVHLNCALWSTEVY	KMT2C	4426	Q8NEZ4
LIAHWLACIWYAIGN	KCNH7	561	Q9NS40
VRAIWIWICHHIEYD	KY	186	Q8NBH2
SILLWVGAFLCWIAY	ATP12A	116	P54707
TFALIAHWLACIWYA	KCNH2	556	Q12809
FGLVAHWLACIWYSI	KCNH5	356	Q8NCM2
HWLACIWYSIGDYEV	KCNH5	361	Q8NCM2
CTFALIAHWLACIWY	KCNH6	406	Q9H252
IAHWLACIWYAIGNV	KCNH6	411	Q9H252
WLQYEIAKVIWCLHT	NRDE2	736	Q9H7Z3
CLWKQYAHLEWLLGN	NRDE2	781	Q9H7Z3
LLAHWMACIWYVIGR	KCNH4	371	Q9UQ05
ALYTAHAQAWAQLWV	PGGHG	226	Q32M88
WHEIVNYICQVIFWI	P2RY12	186	Q9H244
LHCVSWALIFPCYWL	SMPD3	16	Q9NY59
WQYVHCLFLWCRVLS	NOC2L	406	Q9Y3T9
LYHVVGWTDWNLALN	GBA	411	P04062
WCQILLLVNHTDYRW	HTT	1836	P42858
CYSWGVCAAIWALVL	FFAR1	121	O14842
DYQLEGLNWLAHSWC	CHD2	486	O14647
GASWLLAHVLAWTYA	CYP4F2	26	P78329
IVGFLWSCWVLVGYA	BMP5	11	P22003
CQDWLEALHWYNTAL	EEF2K	631	O00418
LYFLWLGCVVLWAQG	FBN2	11	P35556
NVVYHAADLSLWWQV	SLC15A4	441	Q8N697
LWAQRLGHCHTYWAV	IRF3	281	Q14653
VLHLAWVACGYIIWQ	LXN	136	Q9BS40
FLDCHYNWELVIWCI	PHTF2	661	Q8N3S3
IHSLPCDYRANQWAW	TIGD6	241	Q17RP2
AAWICIVRYHQLRDW	TMEM150B	66	A6NC51
EALLCWYHIARAKAW	TIGD3	81	Q6B0B8
HSWILYVAAALWGVG	UNC93B1	431	Q9H1C4
WYIVGIVSWGQSCAL	TMPRSS11F	401	Q6ZWK6
LLYQVWWLQGHVEEC	TEX13C	86	A0A0J9YWL9
WGKIVAQYIHDQWVC	TARBP1	881	Q13395
LYAGLWTLCNHELCW	TMEM202	91	A6NGA9
LCNGYWLAWLIHVGE	TMEM254	61	Q8TBM7
VYVLFGVLWLAWSAC	TMEM87A	236	Q8NBN3
LWVHLNCALWSTEVY	KMT2D	5056	O14686